| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Cardiopulmonary Pathology, Department of Pathology, and Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland
Chronic obstructive pulmonary diseases (COPD), comprised of pulmonary emphysema, chronic bronchitis, and structural and inflammatory changes of small airways, is a leading cause of morbidity and mortality in the world. A better understanding of the pathobiology of COPD is critical for the developing of novel therapies, as the majority of patients with the disease have little therapeutic options at the present time. The pathobiology of COPD encompasses multiple injurious processes including inflammation (excessive or inappropriate innate and adaptive immunity), cellular apoptosis, altered cellular and molecular alveolar maintenance program, abnormal cell repair, extracellular matrix destruction (protease and anti-protease imbalance), and oxidative stress (oxidant and antioxidant imbalance). These processes are triggered by urban and rural air pollutants and active and/or passive cigarette smoke and modified by cellular senescence and infection. A series of receptor-mediated signal transduction pathways are activated by reactive oxygen species and tobacco components, resulting in impairment of a variety of cell signaling and cytokine networks, subsequently leading to chronic airway responses with mucus production, airway remodeling, and alveolar destruction. The authors provide an updated insight into the molecular and cellular pathobiology of COPD based on human and/or animal data.
This article has been cited by other articles:
|
|
 |
|
  T. Fujisawa, S. Velichko, P. Thai, L.-Y. Hung, F. Huang, and R. Wu Regulation of Airway MUC5AC Expression by IL-1{beta} and IL-17A; the NF-{kappa}B Paradigm J. Immunol., November 15, 2009; 183(10): 6236 - 6243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. MacNee and R. M. Tuder New Paradigms in the Pathogenesis of Chronic Obstructive Pulmonary Disease I Proceedings of the ATS, September 15, 2009; 6(6): 527 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Faffe and W. A. Zin Lung Parenchymal Mechanics in Health and Disease Physiol Rev, July 1, 2009; 89(3): 759 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Levy, E. Khan, M. Careaga, and T. Goldkorn Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death Am J Physiol Lung Cell Mol Physiol, July 1, 2009; 297(1): L125 - L133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rangasamy, V. Misra, L. Zhen, C. G. Tankersley, R. M. Tuder, and S. Biswal Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L888 - L900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Kelsen, M. O. Aksoy, M. Georgy, R. Hershman, R. Ji, X. Li, M. Hurford, C. Solomides, W. Chatila, and V. Kim Lymphoid Follicle Cells in Chronic Obstructive Pulmonary Disease Overexpress the Chemokine Receptor CXCR3 Am. J. Respir. Crit. Care Med., May 1, 2009; 179(9): 799 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Deslee, J. C. Woods, C. Moore, S. H. Conradi, D. S. Gierada, J. J. Atkinson, J. T. Battaile, L. Liu, G. A. Patterson, T. L. Adair-Kirk, et al. Oxidative Damage to Nucleic Acids in Severe Emphysema Chest, April 1, 2009; 135(4): 965 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Malhotra, R. Thimmulappa, A. Navas-Acien, A. Sandford, M. Elliott, A. Singh, L. Chen, X. Zhuang, J. Hogg, P. Pare, et al. Decline in NRF2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, DJ-1 Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 592 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yao, S.-R. Yang, I. Edirisinghe, S. Rajendrasozhan, S. Caito, D. Adenuga, M. A. O'Reilly, and I. Rahman Disruption of p21 Attenuates Lung Inflammation Induced by Cigarette Smoke, LPS, and fMLP in Mice Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 7 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Tuder, J. H. Yun, and B. B. Graham Cigarette Smoke Triggers Code Red: p21CIP1/WAF1/SDI1 Switches on Danger Responses in the Lung Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Wright, M. Cosio, and A. Churg Animal models of chronic obstructive pulmonary disease Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L1 - L15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Chung and I. M. Adcock Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yao, I. Edirisinghe, S. Rajendrasozhan, S.-R. Yang, S. Caito, D. Adenuga, and I. Rahman Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1174 - L1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sharafkhaneh, N. A. Hanania, and V. Kim Pathogenesis of Emphysema: From the Bench to the Bedside Proceedings of the ATS, May 1, 2008; 5(4): 475 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Churg, M. Cosio, and J. L. Wright Mechanisms of cigarette smoke-induced COPD: insights from animal models Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L612 - L631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Paleari, P. Russo, A. Cesario, and P. Granone Inflammation and thoracic surgery: a complex interaction Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 950 - 950. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
